.jpg?format=webp&width=780)
The study suggested that sphingolipids might play a crucial role in the link between kidney function and cardiovascular health. Researchers found that altered levels of specific sphingolipids in patients with chronic kidney disease (CKD) are associated with an increased risk of heart failure. The study analyzed over 3,400 participants and identified sphingolipids like ceramide-16:0 as potential mediators of this association. This discovery could pave the way for novel therapeutic approaches targeting sphingolipid metabolism to mitigate heart failure risk in CKD patients.
Like
Save
Share